Adam R. Kalbermatten - 28 Jul 2025 Form 4 Insider Report for KORU Medical Systems, Inc. (KRMD)

Role
Chief Commercial Officer
Signature
/s/ Thomas Adams-Attorney-in-Fact
Issuer symbol
KRMD
Transactions as of
28 Jul 2025
Net transactions value
$0
Form type
4
Filing time
11 Aug 2025, 16:23:25 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KALBERMATTEN ADAM R Chief Commercial Officer C/O KORU MEDICAL SYSTEMS, INC., 100 CORPORATE DRIVE, MAHWAH /s/ Thomas Adams-Attorney-in-Fact 07 Aug 2025 0002080271

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRMD Common Stock Award $0 +300,000 $0.000000 300,000 28 Jul 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRMD Option to buy Common Stock Award $0 +600,000 $0.000000 600,000 01 Aug 2025 Common Stock 600,000 $3.44 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of restricted stock issued as an employment inducement award that vest 25% annually commencing July 28, 2026, subject to acceleration as provided in his employment agreement.
F2 One-fourth will vest on August 1, 2026 and on each first, second and third anniversary thereof.

Remarks:

The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person. Power of Attorney has been previously filed.